Virtu Financial’s Exagen XGN Stock Holding History

Virtu Financial’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,039	Closed	-$70K	–	2168
2025 Q2	$70K	Buy	+10,039	New	+$61K	﹤0.01%	1088
2025 Q1	–	Sell	-11,203	Closed	-$46K	–	2123
2024 Q4	$46K	Buy	+11,203	New	+$40.4K	﹤0.01%	1176

Other funds holding XGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Virtu Financial's XGN Position: Q3 2025 in Review

Virtu Financial sold out of Exagen (XGN) in Q3 2025, closing a stake of 10,039 shares — an estimated $70K sold.

Virtu Financial first reported a position in XGN in Q4 2024 and held it in 2 quarters. The position peaked at $70K in Q2 2025. 62 funds tracked by Wall St. Rank hold XGN as of Q3 2025.

Virtu Financial reported no remaining Exagen position as of Q3 2025 after selling out during the quarter.
Virtu Financial sold 10,039 Exagen shares in Q3 2025, an estimated $70K.
Virtu Financial first reported a position in Exagen in Q4 2024 and held it in 2 quarters.
Virtu Financial's Exagen position peaked at $70K in Q2 2025.
62 funds tracked by Wall St. Rank held Exagen as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.